Pipelines & Platforms
Energenesis is focused on developing innovative therapeutics based on its proprietary ENERGI-Platform, which uses small molecule drugs to enhance cellular energy (ATP) and activate self-healing mechanisms. Main pipelines: 1. ENERGI-F703DFU: gel for Diabetic foot ulcers (Phase III) 2. ENERGI-F703EB: cream for Epidermolysis Bullosa (in preparation for Phase II, granted ODD&RPD) 3. ENERGI-F705PD: oral medicine for Parkinson’s disease ((in preparation for Phase II) 4. ENERGI-F701: hair tonic for Alopecia (Phase II)
Business Interests
Out-Licensing, Distribution, Co-Development, Strategic Alliance
Contact Info
Shelly Yang
BD Manager
+886-2-2627-0835 #803
shelly@energenesis-biomedical.com